- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 100 mg INX-08189 QD
Total 2104 results
-
Genuine Research Center, EgyptBio Med for Pharmaceuticals Industries (BIOMED), EgyptCompleted
-
AstraZenecaParexelActive, not recruitingLocally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung CancerBelgium, United States, Canada, Poland, Romania, Taiwan, Thailand, Vietnam, France, Italy, Korea, Republic of, Brazil, Japan, Turkey, China, Malaysia, Germany, Spain, Australia, Hungary, Portugal, Switzerland, Israel, Philippines, Russian... and more
-
VM Oncology, LLCRecruitingSarcoma | Cervical Cancer | Breast Cancer | Adenoid Cystic Carcinoma | Pancreatic Cancer | Ovarian Cancer | Non-Small Cell Lung Cancer | Thymic Carcinoma | Lung Cancer | Mesothelioma | Bladder Cancer | Head and Neck Carcinoma | Any Solid Tumors Progressed After a Prior ImmunotherapyUnited States, Puerto Rico
-
Cassava Sciences, Inc.National Institute on Aging (NIA)CompletedAlzheimer DiseaseUnited States, Canada
-
SynAct Pharma ApsNBCD A/SCompletedRheumatoid ArthritisMoldova, Republic of
-
PfizerCompletedHealthy Volunteers | Hepatic ImpairmentUnited States
-
Suzhou Kintor Pharmaceutical Inc,Completed
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Cassava Sciences, Inc.National Institute on Aging (NIA)Completed
-
AbbottCompletedIrritable Bowel SyndromePakistan
-
CymaBay Therapeutics, Inc.Completed
-
Aevi Genomic Medicine, LLC, a Cerecor companyCompletedAttention Deficit Disorder With HyperactivityUnited States
-
CelgeneCompleted
-
Pain TherapeuticsNational Institute on Aging (NIA)CompletedAlzheimer Disease | Alzheimer Disease, Early OnsetUnited States
-
McGill University Health Centre/Research Institute...RecruitingESRD | CKD Stage 4 | CKD Stage 5Canada
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompletedHealthyUnited States
-
Novo Nordisk A/SCompletedHealthy Volunteers - Haemophilia AGermany
-
PfizerCompletedHealthy VolunteerNetherlands
-
Wyeth is now a wholly owned subsidiary of PfizerCompletedMajor Depressive DisorderUnited States
-
Emerald Health PharmaceuticalsSuspendedRelapsing Forms of Multiple SclerosisUnited States, Australia
-
SynAct Pharma ApsRecruitingNephrotic Syndrome Due to Idiopathic Membranous Nephropathy | Severe Proteinuria Due to Idiopathic Membranous NephropathyDenmark
-
Tonix Pharmaceuticals, Inc.Completed
-
UCB Pharma SAUCB Japan Co. Ltd.CompletedEpilepsy | Partial Onset SeizuresChina, Japan
-
GlaxoSmithKlineTerminatedCerebrovascular AccidentGermany, Canada, United Kingdom, United States
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate...Completed
-
Merck Sharp & Dohme LLCCompleted
-
AblynxCompletedRheumatoid ArthritisJapan
-
M.H.H. KramerActive, not recruitingType2 DiabetesNetherlands
-
Quark PharmaceuticalsTerminatedNon Arteritic Anterior Ischemic Optic NeuropathyUnited States, Australia, Germany, China, India, Italy, Singapore, Israel
-
Bangabandhu Sheikh Mujib Medical University, Dhaka...CompletedHead and Neck Squamous Cell CarcinomaBangladesh
-
British University In EgyptCompleted
-
Rigel PharmaceuticalsWithdrawn
-
Intira SriprasertTherapeuticsMDCompletedMenopauseUnited States
-
Assistance Publique - Hôpitaux de ParisMerck Sharp & Dohme LLC; Pfizer; AstraZenecaCompletedIschemic Stroke | Transient Ischemic Attack | Atherosclerotic StenosisFrance
-
PfizerCompleted
-
Corcept TherapeuticsRecruitingNonalcoholic Steatohepatitis (NASH)United States
-
Tibotec Pharmaceuticals, IrelandWithdrawn
-
VA Office of Research and DevelopmentCompletedPrediabetic State | Metabolic Syndrome XUnited States
-
United States Army Institute of Surgical ResearchCompletedBurns | Post Traumatic Stress DisordersUnited States
-
Nektar TherapeuticsCompletedColorectal Cancer | TumorUnited States
-
Andrew J. Armstrong, MDCompletedProstate CancerUnited States
-
Centre hospitalier de l'Université de Montréal...Completed
-
Spero TherapeuticsRecruitingNontuberculous Mycobacterial Pulmonary Disease (NTM-PD)United States